PLRX - Pliant downgraded at Stifel on bexotegrast trial discontinuation
2025-03-04 10:32:18 ET
More on Pliant Therapeutics
- Pliant Therapeutics: Strange Volatility
- Pliant dives 49% as it abandons phase 2 trial of bexotegrast for IPF
- Pliant stock jumps 28% on bexotegrast study update
- Seeking Alpha’s Quant Rating on Pliant Therapeutics
- Historical earnings data for Pliant Therapeutics